REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 81 filers reported holding REPROS THERAPEUTICS INC in Q2 2013. The put-call ratio across all filers is 1.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $14,533,000 | +3.9% | 1,955,944 | 0.0% | 0.13% | +8.9% |
| Q2 2015 | $13,985,000 | -18.6% | 1,955,944 | -2.2% | 0.12% | -14.0% |
| Q1 2015 | $17,180,000 | -13.8% | 2,000,000 | 0.0% | 0.14% | -29.9% |
| Q4 2014 | $19,940,000 | -27.5% | 2,000,000 | -28.0% | 0.20% | -41.0% |
| Q3 2014 | $27,509,000 | -42.8% | 2,778,654 | 0.0% | 0.35% | -41.3% |
| Q2 2014 | $48,071,000 | -2.5% | 2,778,654 | 0.0% | 0.59% | -6.1% |
| Q1 2014 | $49,293,000 | -3.1% | 2,778,654 | 0.0% | 0.63% | -12.6% |
| Q4 2013 | $50,849,000 | -31.7% | 2,778,654 | 0.0% | 0.72% | -32.2% |
| Q3 2013 | $74,468,000 | +45.3% | 2,778,654 | 0.0% | 1.06% | +4.3% |
| Q2 2013 | $51,266,000 | – | 2,778,654 | – | 1.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 1,132,367 | $9,727,000 | 2.05% |
| RTW INVESTMENTS, LP | 229,364 | $1,970,000 | 0.89% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 361,300 | $3,104,000 | 0.85% |
| DESTRIER CAPITAL MANAGEMENT LLC | 329,030 | $2,826,000 | 0.73% |
| SENZAR ASSET MANAGEMENT, LLC | 244,006 | $2,096,000 | 0.51% |
| GENERAL AMERICAN INVESTORS CO INC | 508,375 | $4,367,000 | 0.36% |
| CQS Cayman LP | 700,000 | $6,013,000 | 0.28% |
| Rotella Capital Management, Inc. | 20,800 | $179,000 | 0.15% |
| Baker Brothers Advisors | 2,000,000 | $17,180,000 | 0.14% |
| Gruss Capital Management LP | 304,000 | $2,611,000 | 0.11% |